[go: up one dir, main page]

IL236466A0 - Medicament form for release of active ingredients - Google Patents

Medicament form for release of active ingredients

Info

Publication number
IL236466A0
IL236466A0 IL236466A IL23646614A IL236466A0 IL 236466 A0 IL236466 A0 IL 236466A0 IL 236466 A IL236466 A IL 236466A IL 23646614 A IL23646614 A IL 23646614A IL 236466 A0 IL236466 A0 IL 236466A0
Authority
IL
Israel
Prior art keywords
release
active ingredients
medicament form
medicament
ingredients
Prior art date
Application number
IL236466A
Other languages
Hebrew (he)
Other versions
IL236466B (en
Original Assignee
Hennig Arzneimittel Gmbh & Co
Francas Gernot
PRZYKLENK Karl Heinz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hennig Arzneimittel Gmbh & Co, Francas Gernot, PRZYKLENK Karl Heinz filed Critical Hennig Arzneimittel Gmbh & Co
Publication of IL236466A0 publication Critical patent/IL236466A0/en
Publication of IL236466B publication Critical patent/IL236466B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL236466A 2012-06-25 2014-12-25 Medicament form for release of active ingredients IL236466B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012105528.9A DE102012105528A1 (en) 2012-06-25 2012-06-25 Pharmaceutical form for the release of active substances
PCT/EP2013/063162 WO2014001267A2 (en) 2012-06-25 2013-06-24 Medicament form for release of active ingredients

Publications (2)

Publication Number Publication Date
IL236466A0 true IL236466A0 (en) 2015-02-26
IL236466B IL236466B (en) 2019-02-28

Family

ID=48656002

Family Applications (1)

Application Number Title Priority Date Filing Date
IL236466A IL236466B (en) 2012-06-25 2014-12-25 Medicament form for release of active ingredients

Country Status (20)

Country Link
EP (2) EP2863896B1 (en)
AU (1) AU2013283473B2 (en)
BR (1) BR112014032578B1 (en)
CA (1) CA2877190C (en)
CO (1) CO7250447A2 (en)
DE (1) DE102012105528A1 (en)
DK (1) DK2679216T3 (en)
EA (1) EA030871B1 (en)
ES (2) ES2607447T3 (en)
HU (2) HUE031246T2 (en)
IL (1) IL236466B (en)
IN (1) IN2014MN02526A (en)
MX (1) MX367284B (en)
MY (1) MY168531A (en)
PH (1) PH12014502836B1 (en)
PL (2) PL2679216T3 (en)
PT (2) PT2679216E (en)
UA (1) UA118836C2 (en)
WO (1) WO2014001267A2 (en)
ZA (1) ZA201409506B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2936740C (en) 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
EP3431078B1 (en) 2017-07-20 2021-01-20 Intas Pharmaceuticals Limited Non-pulsatile prolonged-release betahistine oral solid compositions
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
DE102018129419A1 (en) 2018-11-22 2020-05-28 Johannes Gutenberg-Universität Mainz Acrylate copolymer for pharmaceutical applications
JP2025536556A (en) 2022-10-25 2025-11-07 ヴェラダーミクス インコーポレイテッド Modified-Release Minoxidil Compositions and Methods of Use
DE102023002336A1 (en) * 2023-06-09 2024-12-12 euvorio GmbH Carbohydrate-containing compositions in dragee form

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
IT1229237B (en) * 1989-05-08 1991-07-26 Prodotti Formenti SALTS OF (2- (PYRIDYL) ETHYL) METHYLAMINE
ATE164514T1 (en) * 1992-08-06 1998-04-15 Gergely Gerhard EASY TO TAKE EFFORTABLE TABLET
HRP970493A2 (en) 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
IT1309591B1 (en) 1999-03-05 2002-01-24 Formenti Farmaceutici Spa COMPOSITIONS WITH BETAISTINE CONTROLLED RELEASE.
DE10010509A1 (en) 2000-03-08 2001-09-13 Dresden Arzneimittel Oral pharmaceutical formulations with controllable release characteristics, e.g. rapid or delayed release, contain sucrose fatty acid ester as drug release controlling agent
DE10104880A1 (en) 2001-01-31 2002-08-08 Roehm Gmbh Multiparticulate pharmaceutical form, containing at least two differently coated pellet forms
ES2306827T3 (en) * 2003-07-04 2008-11-16 Farmaceutici Formenti S.P.A. COMPOSITIONS OF BETAHISTINE CONTROLLED LIBERATION.
US20060280795A1 (en) * 2005-06-08 2006-12-14 Dexcel Pharma Technologies, Ltd. Specific time-delayed burst profile delivery system
CA2683415C (en) * 2007-04-04 2020-12-08 Sigmoid Pharma Limited An oral pharmaceutical composition
WO2012110912A1 (en) * 2011-02-17 2012-08-23 Lupin Limited Sustained release composition of memantine

Also Published As

Publication number Publication date
AU2013283473A1 (en) 2015-01-29
PH12014502836A1 (en) 2015-02-02
CO7250447A2 (en) 2015-04-30
EP2863896B1 (en) 2016-09-14
EP2679216A1 (en) 2014-01-01
EA201500044A1 (en) 2015-05-29
ES2546172T3 (en) 2015-09-21
EP2679216B1 (en) 2015-05-27
DK2679216T3 (en) 2015-08-31
CA2877190A1 (en) 2014-01-03
BR112014032578B1 (en) 2022-07-26
AU2013283473A2 (en) 2015-01-22
MX367284B (en) 2019-08-13
DE102012105528A1 (en) 2014-01-02
IN2014MN02526A (en) 2015-07-17
MY168531A (en) 2018-11-12
ZA201409506B (en) 2016-08-31
EA030871B1 (en) 2018-10-31
PT2863896T (en) 2016-12-21
UA118836C2 (en) 2019-03-25
WO2014001267A3 (en) 2014-03-06
PT2679216E (en) 2015-10-09
MX2014015660A (en) 2015-07-14
CA2877190C (en) 2020-01-07
PL2863896T3 (en) 2017-04-28
PH12014502836B1 (en) 2015-02-02
AU2013283473B2 (en) 2016-10-27
HUE025739T2 (en) 2016-04-28
PL2679216T3 (en) 2015-12-31
HUE031246T2 (en) 2017-06-28
ES2607447T3 (en) 2017-03-31
EP2863896A2 (en) 2015-04-29
BR112014032578A2 (en) 2017-06-27
IL236466B (en) 2019-02-28
WO2014001267A2 (en) 2014-01-03

Similar Documents

Publication Publication Date Title
IL238713A0 (en) Self-regulated release of active pharmaceutical ingredient
ZA201501847B (en) Formulations of enzalutamide
AP2014007922A0 (en) Pharmaceutical formulations of TNF-alpha antibodies
PL2741824T3 (en) Use of estetrol as emergency contraceptive
IL235831B (en) Novel dosage form and formulation of abediterol
IL236465A0 (en) Pharmaceutical form for extended release of active substances
IL236466B (en) Medicament form for release of active ingredients
ZA201502695B (en) Stable pharmaceutical composition of peginterferon alpha-2b
EP2846839A4 (en) Formulations for the delivery of active ingredients
IL239670A0 (en) Monolithic dosage form for modified release of a combination of active ingredients
PT2704698T (en) Dosage form for the controlled release of active ingredients
SG11201406097SA (en) Capsule formulation
TH1401007646A (en) Medicament form for release of active ingredients
GB201104632D0 (en) Use of medicament
AP2015008270A0 (en) Preparation for the treatment of tuberculosis
IL237221A (en) Compositions comprising phospholipid drug analogs
SG11201401570YA (en) Pharmaceutical compositions of resveratrol

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed